Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Gobb, we'll know soon but if they went through the

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Jun 03, 2021 11:33pm

77 Views

Post# 33327656

RE:Gobb, we'll know soon but if they went through the

Will you shut up about $100M deal.

Thats the value of the voucher you thought LMNL was getting and selling.

Man your as dumb as a stump.

realstocky wrote:
trouble of making a 100M$ deal with kedrion, logically they think they'll have the FDA green light, so the inspection is done and it's all ready to go...on the FDA go.